Análise sobre o método de mensuração do valor justo dos ativos biológicos das empresas listadas na B3

Abstract

The objective of this research is to investigate which information (inputs) are applied in the valuation techniques used to measure the fair value of biological assets in the Brazilian companies listed in B3 in the years 2013 to 2015. In Brazil, until the issuance of CPC 29 by the Committee of Accounting Pronouncements in 2009, biological assets were measured at historical cost. After the CPC changes, the biological assets are measured at fair value and this measurement can be classified by levels, known as the fair value hierarchy. This is a descriptive, qualitative and documentary research. After analyzing the consolidated financial statements of the entities, with the aid of the explanatory notes, it was observed that 100% of the companies used the fair value to measure the biological assets, as defined by CPC 29. In this sense, it was verified that the companies mainly used inputs of level 3, notably the discounted cash flow, and only the companies in the meat and derivatives sector used level 1. Possible explanations for this situation refer to the absence of quoted prices in active markets or markets similar for such biological assets.